Skip to main content
Premium Trial:

Request an Annual Quote

Jeremy Bridge-Cook

Rna Diagnostics has appointed Jeremy Bridge-Cook as its president and CEO. Prior to working at Rna Diagnostics, Bridge-Cook worked for 16 years in progressively senior roles in business development, research and development, and general management roles at Tm Bioscience, or TMB. During this time, he also served as a corporate officer and senior vice president of research and development at Luminex, acquired by TMB in 2007.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.